{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:01:58Z","timestamp":1770156118346,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ymgmr.2024.101069","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T17:47:11Z","timestamp":1710438431000},"page":"101069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV"],"prefix":"10.1016","volume":"39","author":[{"given":"Chie","family":"Naito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karis","family":"Kosar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaili","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Bernieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kasten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chet","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bali","family":"Deeksha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2024.101069_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/01913123.2011.601404","article-title":"Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment","volume":"35","author":"Hicks","year":"2011","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0010","series-title":"StatPearls [Internet]","article-title":"Glycogen storage disease","author":"Stone","year":"2022"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0015","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1212\/01.WNL.0000138429.11433.0D","article-title":"Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type iv)","volume":"63","author":"Bruno","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524024605815","article-title":"The variable presentations of glycogen storage disease type iv: a review of clinical, enzymatic and molecular studies","volume":"2","author":"Moses","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0025","series-title":"GeneReviews\u00ae","article-title":"Glycogen storage disease type iv","author":"Magoulas","year":"2013"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.nmd.2003.12.006","article-title":"Fatal infantile neuromuscular presentation of glycogen storage disease type iv","volume":"14","author":"Tay","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1172\/JCI118517","article-title":"Hepatic and neuromuscular forms of glycogen storage disease type iv caused by mutations in the same glycogen-branching enzyme gene","volume":"97","author":"Bao","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0040","article-title":"Diagnosis and management of glycogen storage disease type iv, including adult polyglucosan body disease: a clinical practice resource","volume":"107525","author":"Koch","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-3046.2007.00803.x","article-title":"Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk\/benefit of this procedure","volume":"12","author":"Davis","year":"2008","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5223\/pghn.2018.21.4.365","article-title":"A case of glycogen storage disease iv with rare homozygous mutations in the glycogen branching enzyme gene","volume":"21","author":"Choi","year":"2018","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0055","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5144\/0256-4947.2014.354","article-title":"First fully laparoscopic donor hepatectomy for pediatric liver transplantation using the indocyanine green near-infrared fluorescence imaging in the middle east: a case report","volume":"34","author":"Troisi","year":"2014","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.992406","article-title":"A novel approach to characterize phenotypic variation in gsd iv: Reconceptualizing the clinical continuum","volume":"13","author":"Kiely","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2013.4888","article-title":"Branching enzyme deficiency: expanding the clinical spectrum","volume":"71","author":"Paradas","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/1531-8249(200004)47:4<536::AID-ANA22>3.0.CO;2-K","article-title":"Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease","volume":"47","author":"Ziemssen","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.gim.2021.09.016","article-title":"Implementation of fetal clinical exome sequencing: comparing prospective and retrospective cohorts","volume":"24","author":"Marangoni","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nmd.2022.12.016","article-title":"Distinct features in adult polyglucosan body disease: a case series","volume":"33","author":"De Winter","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40246-020-00276-2","article-title":"Application of crispr\/cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery","volume":"14","author":"De Masi","year":"2020","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc01g04s26","article-title":"Differentiation of hepatocytes from pluripotent stem cells","volume":"26","author":"Mallanna","year":"2013","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0095","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.109.868885","article-title":"Cardiomyocyte differentiation of human induced pluripotent stem cells","volume":"120","author":"Zwi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0100","article-title":"Human ipsc-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency","volume":"4","author":"Li","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0105","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep4.1111","article-title":"Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine","volume":"1","author":"Takayama","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0110","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"Crispor: intuitive guide selection for crispr\/cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0115","first-page":"1056","article-title":"Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells","volume":"144","author":"Asai","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0125","first-page":"52010","article-title":"High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry","author":"Bhattacharya","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1073\/pnas.56.2.725","article-title":"Lack of an alpha-1,4-glucan: Alpha-1,4-glucan 6-glycosyl transferase in a case of type iv glycogenosis","volume":"56","author":"Brown","year":"1966","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.a.30945","article-title":"Fetal type iv glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family","volume":"139A","author":"L\u2019Hermine-Coulomb","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5114\/aoms.2018.72246","article-title":"Variable clinical presentation of glycogen storage disease type iv: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities","volume":"14","author":"Szymanska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced pluripotent stem cells and their use in human models of disease and development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0150","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.csbj.2019.07.015","article-title":"Drug inducible crispr\/cas systems","volume":"17","author":"Zhang","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-019-0578-x","article-title":"Human ipsc banking: barriers and opportunities","volume":"26","author":"Huang","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0160","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1038\/srep11319","article-title":"A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture","volume":"5","author":"Beers","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.stemcr.2019.12.007","article-title":"Negligible-cost and weekend-free chemically defined human ipsc culture","volume":"14","author":"Kuo","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0170","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","article-title":"Induced pluripotent stem cells in disease modelling and drug discovery","volume":"20","author":"Rowe","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4252\/wjsc.v11.i1.33","article-title":"Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Machiraju","year":"2019","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0180","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1089\/scd.2017.0270","article-title":"In vitro pluripotent stem cell differentiation to hepatocyte ceases further maturation at an equivalent stage of e15 in mouse embryonic liver development","volume":"27","author":"Raju","year":"2018","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0185","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2014.10.016","article-title":"Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes","volume":"62","author":"Baxter","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgmr.2024.101069_bb0190","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.placenta.2008.01.005","article-title":"Placental involvement in glycogen storage disease type iv","volume":"29","author":"Konstantinidou","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.ymgmr.2024.101069_bb0195","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2559.2006.02425.x","article-title":"Neonatal neuromuscular variant of glycogen storage disease type iv: histopathological findings leading to the diagnosis","volume":"48","author":"Konstantinidou","year":"2006","journal-title":"Histopathology"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T20:09:31Z","timestamp":1723147771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"alternative-id":["S2214426924000223"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101069","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101069"}}